This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer
Clinical trial NCT03099174 · COMPLETED
Trial details
- NCT number
- NCT03099174
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-04
- Primary completion
- 2023-05-31
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.